Biochemical Reagent
-
BA8179 Enpp-1-IN-2Summary: Enpp-1-IN-2 is a potent (ectonucleotide pyrophosphatase/phosphodiesterase 1) inhibitor with values of 0.26, 0.48, and 2.0 μM as determined by TG-mAMP, pNP-TMP, and ATP methods, respectively. -
BA8180 TAK-915Summary: TAK-915 is a potent, selective, blood-brain barrier-crossing and orally active inhibitor.
-
BA8181 PDE12-IN-3Summary: PDE12-IN-3 is a phosphodiesterase 12 inhibitor with a pXC of 7.68.
-
BA8182 DSR-141562Summary: DSR-141562 is a novel, orally active phosphodiesterase inhibitor that crosses the blood-brain barrier.
-
BA8183 Autotaxin-IN-3Summary: Autotaxin-IN-3 is an inhibitor.
-
BA8184 DovramilastSummary: Dovramilast (CC-11050) is a phosphodiesterase 4 inhibitor with oral activity that reduces the inflammatory response and improves mediated lung bacterial clearance.
-
BA8185 CarbazeranSummary: Carbazeran is a potent phosphodiesterase inhibitor and is an aldehyde oxidase substrate.
-
BA8186 FCPR03Summary: FCPR03 is a potent and selective phosphodiesterase 4 inhibitor.
-
BA8187 OglemilastSummary: Oglemilast (GRC3886) is an orally active phosphodiesterase 4 inhibitor.
-
BA8188 BRD9500Summary: BRD9500 is a potent, orally active phosphodiesterase 3 inhibitor.